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Amino-Acid-Derived Naphthalenediimides as Versatile G-
Quadruplex Binders
Dora M. Ra˘sa˘dean,[a] Bin Sheng,[a] Jyotirmaee Dash,[b] and G. Dan Pantos¸*[a]
Abstract: The design and synthesis of water soluble, amino-
acid-functionalised naphthalenediimides (NDIs) as potential
ligands of native G-quadruplexes is reported. The NDIs were
tested on a panel of oncogene promoters, on the human te-
lomeric sequence h-telo, and on double-stranded DNA. Out
of the ligands tested, NDI 3 (Ne-Boc-l-lysine-protected NDI)
exhibited a highly discriminating nature by only stabilising
the oncogene promoter c-kit2, which is up-regulated up to
80% in ovarian, gastrointestinal, and breast malignancies.
Introduction
DNA is a pivotal target in anticancer therapy, and a large
number of clinically approved drugs directly interact with it.[1]
Of the nucleobase units that comprise the human genome,
guanines (G) have the propensity to self-assemble into higher-
order structures known as G-quadruplexes.[2] The constitutive
element of these stacked G-rich structures is a relatively planar
configuration of four guanines stabilised by a cyclic Hoogsteen
hydrogen bonding network.[3,4] G-quadruplex DNA displays
polymorphic structural forms, which show three major folding
topologies that are distinguished based on their strands’ orien-
tation: parallel, antiparallel, or a hybrid conformation of the
two (Figure 1). The complexity and intricacy of these topolo-
gies is highlighted by their ability to form either intra- or inter-
molecular G-quadruplex motifs with loops and grooves that
confer binding preferences.[5]
Recent studies indicate that these secondary structures are
encountered in gene bodies.[6] They are also present in other
key targets of anticancer therapy, such as introns and double-
strand breaks.[1, 5] G-quadruplexes have been postulated to
govern several crucial biological processes within the chromo-
some and to regulate transcription, translation, and replica-
tion.[1,7–10]
Generally, over-expression of the telomerase enzyme in tu-
mours leads to chaotic and unlimited elongation of the telo-
mere. Thus, anticancer therapies aim to reduce telomerase ac-
tivity; this leads to stabilised telomeric G-quadruplexes.[1] Such
approaches could initiate generate uncapping processes, chro-
mosomal fusions, and senescence, which would eventually
trigger DNA alteration and apoptosis.[11,12]
Owing to the unique topology of each G-quadruplex struc-
ture, the prospect of generating highly selective and effective
molecules towards the stabilisation of G-rich DNA over dsDNA
is promising, but challenging.[13] A relatively large number of
small ligands, such as Telomestatin, Quarfloxin, prophyrinoids,
amido-anthraquinones, quindoline, and acridine deriva-
tives,[6, 14–38] that interact with these higher-order structures
have been developed, several of which have entered clinical
trials.[1, 39,40] Figure 2 illustrates the various G-quadruplex bind-
ing modes adopted by small ligands; an example not included
in this Figure, which stands out as a unique binding mode, is
the threading and stacking interaction, whereby a polyaromatic
moiety that bears an alkyl triamine group replaces the alkaline
cations and stacks on the top G-tetrad.[29] Naphthalenediimi-
de(NDI)-based compounds have been shown to have a high
affinity for G-quadruplexes and have inhibited the telomerase
activity at telomeres as a result of h-telo stabilization. The suc-
cess of these ligands is due to their extended planar heteroaro-
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Figure 1. Schematic representation of the structural unit of a G-quadruplex
(held together by a cyclic hydrogen-bonding network) and its polymorphic
nature.[10] .
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matic surface, which facilitates aromatic stacking interactions
with the G-tetrads.
From a synthetic perspective, the fused p-rings of the NDI
core provide an excellent platform for the subsequent attach-
ment of scaffolds that can electrostatically interact with the
grooves.[41] To date, the NDI-based G-quadruplex ligands in-
clude di or tetrasubstituted derivatives that bear either aromat-
ic or aliphatic side chains.[41, 42]
Herein, we report the stabilisation potential of certain amino
acid functionalised NDIs against a panel of G-quadruplex se-
quences, which include the human telomeric h-telo and the
oncogene promoters c-Myc, c-kit, and k-ras as well as
a double-stranded DNA (dsDNA). To investigate the thermody-
namic driving forces that dominate NDI–G-quadruplex DNA
stabilisation and their susceptibility to self-assemble into supra-
molecular architectures, we conducted temperature-depen-
dent CD spectroscopy.
Results and Discussion
Ligand and condition optimisation
The symmetrical, disubstituted NDI derivatives (1–5, Scheme 1)
were designed for optimum pharmacological behaviour. The
planar NDI core can stack on the surface of a guanine tetrad
through aromatic stacking interactions, and the amino acid
side chains were introduced to increase the water/buffer solu-
bility and interaction with the DNA loops. Lysine and arginine
were selected as the amino acid side chains owing to their
structure and complementary charge to the G-quadruplex
backbone.[1,41–44] The length of the side chain plays a key role
in tethering the G-quadruplex DNA binding ligands; a good
correlation between shorter linker chains and their affinity for
G-quadruplex DNAs over duplex DNA has been reported.[44]
Additionally, the attachment of cationic charges on the periph-
eral substituents increase the aqueous solubility and is likely to
influence the binding selectivity. The ligands have been de-
signed as pairs of the same amino acid (Na-l-lysine and Ne-l-
lysine): the Boc-protected form and its ammonium trifluoroace-
tate counterpart for NDIs 1–4, whereas NDI 5 is the sole argi-
nine functionalised compound of the series.[45]
The synthesis of the symmetric amino acid functionalised
NDIs has involved a microwave-assisted strategy, which was
based on a protocol that we have previously reported.[46,47] We
employed naphthalenetetracarboxylic dianhydride and the cor-
responding protected amino acids as starting materials for
NDIs 1, 3, and 5. NDIs 2 and 4 were obtained by deprotec-
tion[48] of NDIs 1 and 3, respectively (Scheme 1).
These ligands are water soluble, as indicated by linear Lam-
bert–Beer plots of the absorption of solutions. An exception is
NDI 2, which has been shown to aggregate in aqueous solu-
tions at concentrations above 1.9mm.[49] In light of this, all of
the DNA binding studies assumed a non-aggregated state for
all ligands except NDI 2. In this case, the Tm values reflect not
only the (de)stabilisation of the quadruplex sequence but also
account for the de-aggregation of NDI 2 (a process inherently
unfavourable under these conditions).
Fluoride salts, unlike chloride or bromide ones, are transpar-
ent in the far-UV and VUV&&please define&& region; there-
fore, potassium fluoride was selected as a cation source, which
allowed us to monitor the behaviour of the system to wave-
lengths as low as 184 nm.[50]
Figure 2. Schematic representation of the principal binding modes to G-
quadruplexes adopted by ligands.
Scheme 1. Structures of the NDI derivatives employed in this study.
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CD/ UV/Vis-based structural analysis of the adopted topolo-
gies of G-quadruplexes
The CD spectrum is not a reflection of the G-quadruplex DNA
base achiral sequence, but rather it is a consequence of the
chiral environment induced by the sugar backbone. Therefore,
the CD spectrum shows the local structural features of a confor-
mation rather than of the overall sequence.[50,51] The CD finger-
print of each G-quadruplex depends on the glycosyl torsion
angles, namely syn or anti. The latter corresponds to parallel
topologies that contain chain-reversal loops; by contrast, the
antiparallel-stranded G-quadruplex is characterised by a mixture
of both conformers and diagonal loops.[35,52] In general, the CD
spectra of parallel motifs display a positive peak around
260 nm and a negative peak near 240 nm, whereas a positive
peak at 290 nm and a negative peak at 260 nm are commonly
assigned to antiparallel conformations.[52] Figure 3 illustrates
the polymorphic nature of G-quadruplex-forming sequences
investigated in this work.
All the investigated sequences adopted a parallel topology
in PBS (phosphate buffered saline) that contained potassium
fluoride (100mm), except for the telomeric sequence h-telo,
which folds in an antiparallel manner (Figure 3). Each spectrum
of the ligand–G-quadruplex complexes were compared to the
CD spectrum of the sequence itself, and as expected, we ob-
served a drop in the relative intensities.
c-kit1 and c-kit2 are putative G-quadruplex-forming sequen-
ces within the same promoter; c-kit1 is located between 87
and 109 nucleotides, whereas c-kit2 appears between 140
and 160 base pairs.[13,52] The CD and UV spectra of the c-kit1
sequence in the presence of NDIs 1, 3, 4, and 5 showed the
typical spectral signatures of a parallel-stranded conformation
that bears short loops. This is based on the assumption that
the loops are too short to interact with opposite guanine units
within the same quadruplex,[52] but they can bridge guanines
of distinct G-rich strands, which leads to double-chain reversal
loops. The CD spectra also revealed a shoulder peak at 295 nm
(assigned as an extended tail of the main peak) and two small-
er, but well-defined, positive peaks in the far-UV region.
The CD profiles of NDIs 1, 3, 4, and 5 interacting with the c-
kit2 sequence also display a large positive peak at 262 nm
(without the shoulder peak), and a less intense negative peak
at 241 nm, which indicate a parallel topology with small pro-
peller-like loops. In contrast to c-kit1, this sequence exhibits
a sole positive peak centred at 207 nm with a poorly defined
shoulder around 190 nm. This is slightly shifted upon the addi-
tion of ligands; c-kit1--NDI 4 assembly shows the most promi-
nent shoulder extension.
The spectral characteristics of molecular assemblies made
up of oncogene promoters k-ras and c-Myc interacting with
NDIs 1, 3, 4, and 5 in the presence of K+ were similar to those
highlighted for c-kit2 ; therefore, the peaks were ascribed to
a parallel-stranded conformation with short loops. For the k-
ras sequence, the shoulder peak at 194 nm followed the same
trend, with NDI 4 giving the highest positive peak. Distinctive-
ly, the CD spectra for the unbound and bound c-Myc sequence
exhibit a stronger peak around 205 nm with shoulders at
higher wavelengths.
Unlike the promoter G-quadruplex-forming sequences, the
human telomere h-telo incorporates single-stranded overhangs
folded in a unimolecular manner.[53] This sequence adopts an
antiparallel topology in the presence of K+ , as indicated by
a broad positive peak centred at 291 nm and a positive peak
near 205 nm. The CD spectrum reveals a sharp positive peak
having large ellipticity around 189 nm, which raises the ques-
tion whether the spectral motif from the far-UV region could
serve as a signature for topology identification. The h-telo con-
formation is highly polymorphic, depending on the conditions
employed, and is associated with three connecting loops.[54]
As discussed, the appropriate assignment of the pattern
identified under 200 nm (far-UV) was carefully conducted to
understand whether this is correlated to the conformational
fluctuations induced by the binding effect or a fingerprint for
the G-quadruplex DNA itself. The CD spectra of the native G-
quadruplexes did not vary considerably compared with the
spectra of NDI–G-quadruplex assemblies (albeit a small shift of
1–2 nm, particularly for c-kit1 sequence) and are in good
agreement with the CD spectra reported in the literature for
the same sequences.[53] This indicates that the ligand has only
a small influence on the far-UV peaks that are associated with
the quadruplex structures.[53,55]
Figure 3. The CD spectra of G-quadruplex sequences involved in this study.
Each individual sequence folds in distinct topologies in the presence of K+
(data collected at 23 8C in 10mm potassium phosphate buffer and 100mm
potassium fluoride). Unique CD patterns for the parallel conformers, a) 10mm
c-kit2, b) 11mm c-kit1, c) 12mm c-Myc, d) 20 mm k-ras, as well as the antiparal-
lel assembly e) 9mm h-telo. (f) CD fingerprint of 12mm dsDNA.
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CD thermal melting studies
The ability of each NDI molecule to selectively stabilise the
DNA sequences was assessed by performing variable-tempera-
ture CD/UV studies. The melting temperature (Tm) is defined as
the equilibrium condition between the folded and unfolded
states of a particular assembly.[56] Tm is influenced by multiple
factors (i.e. , cooperativity of binding, ligand’s affinity for a par-
ticular conformation, and number of available binding sites),
which determine the overall stability of ligand–G-quadruplex
interaction.[50] A CD melting spectrum also provides details on
the melting profile, as it may be either single-step denatura-
tion or a concerted process that involves several intermediate
states.[54]
Thermal stabilisation studies were performed over a broad
wavelength range (184–450 nm) in the presence of K+ , and Tm
was monitored for each relevant wavelength. The measure-
ments were conducted in mixtures that contained 3 or 10 mm
of preannealed DNA and 10 equivalents of NDI.
The Tm value was determined from the temperature versus
degree of ellipticity plot by means of singular value decompo-
sition (SVD) and Boltzmann mathematical models; both of
which have provided similar results for all sequences. The Tm
and DTm values for G-quadruplexes and dsDNA used in this
study are summarised in Tables 1–5, which show the tempera-
tures obtained from fitting the Boltzmann model to the experi-
mental data. The analysis of the negative peak near 240 nm
displayed large errors for several sequences (c-kit1, c-kit2, c-
Myc) owing to a low ellipticity in this region, and the CD signal
near 185 nm gave large errors in certain cases, because it ap-
proached the lowest detection limit of our CD setup. There-
fore, the peaks that corresponded to these wavelengths were
excluded from further investigation.
Although the c-kit2 sequence displayed the highest melting
temperature within the G-quadruplexes panel, three out of the
five amino acid functionalised NDIs stabilised its structure. NDI
3 showed a strong stabilisation towards this sequence, which
was highlighted by a remarkable increase in Tm of 14.6 8C for
the peak attributed to G-quadruplex motif at 264 nm (the CD
melting associated spectrum for c-kit2–NDI 3 is shown in
Figure 4; the other associated CD meting spectra are provided
in the Supporting Information, Figure S1). NDI 1 and 2 dis-
played moderate stabilisation, whereas the other ligands ex-
hibited only modest stabilisation or even destabilisation to-
wards this sequence (Table 1).
NDIs 1 and 2 displayed a similar ability to stabilise c-kit2 ;
therefore, the presence of the Boc group in the protected NDI
1 did not seem to make a difference in terms of quadruplex
stabilisation. However, as will be discussed later, the high Tm
that was observed for NDI 2 is not representative of its “real”
stabilisation ability owing to its ability to aggregate in solution.
Contrary to this, NDIs 3 and 4 displayed an opposite behav-
iour: the Boc-protected lysine ligand (NDI 3) provided the larg-
est variation, and thus, the best stabilisation, whereas NDI 4
destabilised c-kit2. We postulate that the stabilisation potential
of NDI 3 and its selective nature is facilitated by the Ne-Boc-
protecting group, which provides a highly favourable interac-
tion within the quadruplex cavity loops.
The CD thermal studies of c-kit2–NDI assemblies revealed an
inverted-sigmoid melting profile with isosbestic points around
250 and 220 nm, which indicates a monophasic transition
across the studied temperature range. This feature is lacking
below the 200 nm region, which shows rather hypsochromic-
shifted (blue-shifted) peaks as the temperature increased. Be-
cause this region cannot be correlated with the observed top-
ology, such behaviour does not provide valuable information
about the process of assembly unfolding during the analysis.
Although G-quadruplex-forming c-kit1 and c-kit2 sequences
emerged from the same core promoter,[13] the NDI ligands can
discriminate between them; c-kit1 is only moderately stabilised
or even destabilised in the presence of our ligands (Table 2).
The CD melting associated spectra of c-kit1 with NDIs 1–5 are
shown in Figure S2 (see the Supporting Information).
The promoter c-Myc was also considerably stabilised by NDI
1 and 2, as shown in Table 3. The selective stabilisation of this
G-quadruplex sequence by NDIs 1 and 2 and not by NDIs 3–5
indicates that the steric hindrance/electrostatic requirements
represented by the a-COOH group on the side chain adversely
influence the interaction. The interaction between NDIs 1 and
2 is most likely through the flat aromatic NDI core, with minor
contributions from the aliphatic side chains.
Table 1. Tm and DTm values determined from variable-temperature (VT&
&ok?&& ) CD studies monitored at a relevant wavelength for the c-kit2
sequence upon addition of NDIs 1–5. The Boltzman equation was fitted
to the experimental data.
Sequence/Assembly Tm [8C] DTm [8C] l [nm]
c-kit2 78.22.7 – 262
NDI 1 88.48.4 10.2 264
NDI 2 88.77.1 10.5 264
NDI 3 92.85.9 14.6 264
NDI 4 75.10.9 3.1 262
NDI 5 72.31.0 5.9 262
Figure 4. The CD spectra associated with the melting of 3mm c-kit2 G-quad-
ruplex sequence that was interacting with NDI 3 (data collected at 23 8C in
10mm potassium phosphate buffer and 100mm potassium fluoride).
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The propeller-like parallel conformation is retained; the li-
gands induced only a small shift in the peak pattern, as high-
lighted for NDI 1 in Figure 5 (see the Supporting Information,
Figure S3, NDIs 2–5).
In terms of oncogene promoter k-ras and human telomere
h-telo stabilisation, NDI 4 displayed the best, albeit minor, sta-
bilisation (4 and 2 8C, respectively; Table 4).
As in the case of c-Myc, the parallel and antiparallel topolo-
gies did not change significantly as the temperature was in-
creased, but isosbesticity was lost in the far-UV region. The CD
melting profile spectra of k-ras and h-telo interacting with NDI
4 are shown in Figure 6, and the rest of the spectra are given
in Figures S4 and S5 (see the Supporting Information).
Lastly, the stabilisation effect of NDI ligands on dsDNA was
also investigated. The CD melting profile of dsDNA interacting
with NDIs 1–5 revealed two positive peaks near 270 and
218 nm as well as a negative peak around 250 nm. The far-UV
region was dominated by an intense, broad positive peak cen-
tred at 193 nm. Similar to the melting CD spectra of G-quadru-
plexes, the clear isosbestic points observed across the UV
Table 2. Tm and DTm values determined from VT CD studies monitored at
a relevant wavelength for the c-kit1 sequence upon addition of NDIs 1–5.
The Boltzman equation was fitted to the experimental data.
Sequence/Assembly Tm [8C] DTm [8C] l [nm]
c-kit1 65.80.7 – 262
NDI 1 67.51.0 1.7 263
NDI 2 68.00.8 3.0 262
NDI 3 64.30.4 1.5 263
NDI 4 65.60.7 0.2 264
NDI 5 66.30.5 0.5 262
Table 3. Tm and DTm values determined from VT CD studies monitored at
a relevant wavelength for the c-Myc sequence upon addition of NDIs 1–
5. The Boltzman equation was fitted to the experimental data.
Sequence/Assembly Tm [8C] DTm [8C] l [nm]
c-Myc 63.01.5 – 264
NDI 1 72.21.5 9.2 264
NDI 2 74.23.8 11.1 265
NDI 3 63.12.7 0.1 265
NDI 4 65.21.9 2.2 264
NDI 5 63.24.1 0.2 264
Figure 5. The CD spectra associated with the melting of 12mm c-Myc G-
quadruplex sequence that was interacting with NDI 1 (data collected at
23 8C in 10mm potassium phosphate buffer and 100mm potassium fluo-
ride).
Table 4. Tm and DTm values determined from VT CD studies monitored at
a relevant wavelength for the k-ras and h-telo (italics) sequences upon ad-
dition of NDIs 1–5. The Boltzman equation was fitted to the experimental
data.
Sequence/Assembly Tm [8C] DTm [8C] l [nm]
k-ras 58.30.6
–
262
h-telo 62.50.3 292
NDI 1
60.60.3 2.3 263
61.80.4 0.7 290
NDI 2
58.71.1 0.4 263
61.41.0 1.1 290
NDI 3
60.00.5 1.7 263
61.50.6 1.0 291
NDI 4
62.40.4 4.1 263
64.50.4 2.0 290
NDI 5
60.10.5 1.8 263
62.80.6 0.3 292
Figure 6. The CD spectra associated with the melting of 12mm k-ras G-quad-
ruplex sequence that was interacting with NDI 4 (top) and 9mm h-telo se-
quence with NDI 4 (bottom) (data collected at 23 8C in 10mm potassium
phosphate buffer and 100mm potassium fluoride).
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region were missing below 200 nm. Moreover, the CD finger-
print of dsDNA did not change considerably upon addition of
the ligand (see the Supporting Information, Figure S6).
The melting studies showed either destabilisation or minor
stabilisation for NDIs 1 and 4 (under 2 8C), which is reflected in
the Tm values (Table 5). This suggests that our ligands do not
undergo a significant interaction with dsDNA, which confirms
that these ligands are selective binders of certain G-quadruplex
sequences.
An essential question that arises when studying such assem-
blies is related to the mode of ligand interaction with the G-
quadruplex core. With respect to our rational design of NDI de-
rivatives, we assume that non-covalent forces, namely aromatic
stacking interactions within the quasi-planar guanine tetrads
and hydrogen bonding networks, are the principal binding in-
teractions adopted by these molecules.
The heat map in Figure 7 concisely describes the stabilisa-
tion potential of individual NDIs that is induced on each DNA
sequence. NDI 3 exhibited the greatest stabilisation towards
the c-kit2 sequence, whereas the same molecule had only
a modest effect on the rest of the panel. NDI 5 displayed the
least favourable binding potential towards these higher-order
structures.
The effective impact of NDIs 3 and 1 towards c-kit2 stabilisa-
tion is particularly noteworthy, because this oncogene promot-
er is overexpressed up to 80% in ovarian, gastrointestinal, and
breast malignancies.[13] The roles of the c-kit sequence cover
essential biological processes, from the regulation of apoptosis
and differentiation to cell survival.[13]
Unravelling the behaviour of the interaction between NDI 2
and G-quadruplex DNA
The behaviour exhibited by G-quadruplex–NDI 2 assemblies
were studied further owing to the peculiar binding data that
was observed for this ligand when compared with the other
NDIs employed. The CD spectra of these complexes, regardless
of the type of sequence (Figure 8, c-kit2 interacting with this
NDI 2 ; see the Supporting Information, Figure S7, other G-
quadruplex sequences), displayed a CD signal centred at
381 nm, which was ascribed to the NDI core. This led us to
propose that this ligand is involved in a binding competition
between the self-aggregation process[49,57–62] and the interac-
tion with the G-quadruplex sequences.
To investigate the self-aggregation process, we performed
variable-temperature studies on a sample of NDI 2 in potassi-
um phosphate buffer (pH 7.4), as for the DNA–ligand experi-
ments. The CD fingerprint of NDI 2, the melting curve profile,
and thermodynamic functions associated with the process are
shown in Figure 9. As determined from fitting the isodesmic
polymerisation model, the percentage of monomeric NDI 2 in
the solution dominated at low temperature, but this decreased
as the temperature increased. At temperatures above 338 K
(65 8C), which is the Tm for this molecule, we only observed
50% of monomeric NDI, and the degree of polymerisation was
gradually increased.
The positive value of DS indicates that an entropically fav-
oured process governs the self-assembly of this molecule. This
behaviour is typical for an aromatic stacking/hydrophobic in-
teraction.
Conclusions
The stabilisation of G-quadruplex DNA as the target in anti-
cancer therapy is of broad and current interest, and the design
of ligands with unique affinity towards one G-quadruplex-
forming sequence is challenging. Out of the five ligands that
Table 5. Tm and DTm values determined from VT CD studies of sequences,
which were monitored at a relevant wavelength for dsDNA, upon addi-
tion of NDIs 1–5. The Boltzman equation was fit to the experimental
data.
Sequence/Assembly Tm [8C] DTm [8C] l [nm]
dsDNA 55.10.8 – 273
NDI 1 57.01.2 1.9 273
NDI 2 55.80.7 0.7 273
NDI 3 52.60.8 2.5 273
NDI 4 56.91.5 1.8 273
NDI 5 52.41.8 2.7 274
Figure 7. The heat map table, which displays the DTm values at 260, 270,
and 290 nm that correspond to each NDI and G-quadruplex assembly inves-
tigated in this study. The trend decreases from green to red coding.
Figure 8. The CD melting spectra of the assembly that is formed between
NDI 2 and 12mm c-kit2 (data collected at 23 8C in 10mm potassium phos-
phate buffer and 100mm potassium fluoride).
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we screened against five biologically relevant G-quadruplexes,
NDI 3 only stabilised c-kit2, whilst the parallel topology of the
sequence was maintained. This discrimination is remarkable,
especially because NDI 3 has a small destabilisation effect on
c-kit1. Somewhat surprisingly, the Boc-protected NDI deriva-
tives stabilise the G-quadruplexes equally well or stronger
when compared with their positively charged analogues. This
highlights the delicate balance between polarity and hydro-
phobicity that needs to be achieved for efficient quadruplex
binding. Overall, the NDI ligands are superior for stabilising the
c-kit2 and c-Myc sequences over c-kit1, k-ras, h-telo, and
dsDNA. This work paves the way towards a deeper under-
standing of the structure–activity relationship between NDI li-
gands and G-quadruplexes. Further work on NDI–G-quadruplex
binding studies are currently underway in our group, and it
will be published in due course.
Experimental Section
Materials
The guanine-rich oligonucleotides were purchased from Invitro-
gen, and the nucleotides order in the sequence were as follows
(from 5’ to 3’): c-kit2 : GGG CGG GCG CGA GGG AGG GG; c-kit1:
GGG AGG GCG CTG GGA GGA GGG; c-Myc : TGA GGG TGG GTA
GGG TGG GTA A; k-ras : AGG GCG GTG TGG GAA GAG GGA AGA
GGG GGA GG; h-telo : AGG GTT AGG GTT AGG GTT AGG GT; dsDNA:
TAT AGC TAT AHE GTA TAG CTA. The oligonucleotide solutions
(3mm for c-kit2 and 10mm for the rest of the sequences) were pre-
viously annealed in 10mm KH2PO4/K2HPO4 buffer (pH 7.4) and
100mm KF, and they were used without further purification. The
annealed DNA was stored at 4 8C prior to use.
All the other reagents and solvents were supplied by either
Sigma–Aldrich, VWR, or TCI. Samples for NMR spectroscopy were
made up with [D6]DMSO. NMR spectra were acquired on a Bruker
spectrometer at 300 MHz for 1H NMR and 75 MHz for 13C NMR;
they were referenced to the residual solvent peaks. All spectra
were recorded at 298 K, and data were reported in ppm. The NSI
spectra (negative ion) were recorded on a LTQ Orbitrap XL hybrid
FTMS instrument. Microwave-assisted reactions were conducted in
a CEM microwave reactor.
Synthesis of symmetrical amino acid functionalised NDIs 1,
3, 5
1,4,5,8-Naphthalenetetracarboxylic dianhydride (NDA) and the cor-
responding amino acid were suspended in dry DMF (5 mL) in a mi-
crowave tube. Dry Et3N (0.2 mL) was added, and the mixture was
sonicated until it became a fine suspension. The reaction mixture
was heated under microwave irradiation for either 5 min (NDIs
1 and 3) or 10 min (NDI 5) at 140 8C. The solvent was removed
under reduced pressure to yield a brown residue, which was fur-
ther suspended in acetone. The suspension was added dropwise
to stirring HCl(aq.) (0.25m). The resulting precipitate was filtered and
dried in vacuum to yield a coloured solid.
NDI 1:[49] The reaction was performed on 1 equivalent of NDA
(200 mg, 0.746 mmol) and 2 equivalent of Na-Boc-l-lysine (367 mg,
1.491 mmol) by using the general procedure. Yield of NDI 1:
461 mg, 85%; 1H NMR: d=12.42 (br &&s or m?&&indicate
range if m, also below&&, 2H,), 8.63 (s, 4H), 7.06 (d, J(H,H)=7.9 Hz,
2H), 4.03 (4H, t, J(H,H)=7.2 Hz), 3.86–3.79 (m, 2H), 1.47–&& ppm
(m, 30H); 13C NMR: d=174.6, 163.0, 156.0, 130.8, 126.6, 126.5, 78.2,
53.7, 30.84, 28.5, 27.38.0, 23.6 ppm; FTMS-NSI: m/z calcd for
C36H44N4O12: 723.2856 [MH] ; found: 723.2883.
NDI 3 :[46] The reaction was performed on 1 equivalent of NDA
(200 mg, 0.746 mmol) and 2 equivalent of Ne-Boc-l-lysine (367 mg,
1.491 mmol) by using the general procedure. Yield of NDI 3 :
383 mg, 72%; 1H NMR: d=12.93 (s, 2H), 8.73 (s, 4H), 6.70 (t, J(H,H)=
5.7 Hz, 2H), 5.50 (dd, J(H,H)=9.4, 5.0 Hz, 2H), 2.85–2.74 (m, 4H),
2.28–2.12 (m, 2H), 2.12–1.95 (m, 2H) 1.45–1.05 ppm (m, 26H);
13C NMR: d=171.0, 162.7, 155.8, 131.6, 126.7, 126.3, 77.5, 53.9,
36.2, 31.1, 29.7, 28.4, 23.6 ppm; FTMS-NSI : m/z calcd for
C36H44N4O12: 723.2867 [MH]; found: 723.2883.
NDI 5 : The reaction was performed on 1 equivalent of NDA
(100 mg, 0.373 mmol) and 2 equivalents of HArg(NO2)OH
(163.5 mg, 0.746 mmol) by using the general procedure. Yield of
NDI 5 : 100 mg, 44%; 1H NMR: d=12.95 (s, 2H), 8.65 (s, 4H), 8.42
(br&&s or m?&&indicate range if m, also below&&, 2H), 7.76
(br, 4H), 5.47 (dd, J(H,H)= =9.6, 4.7 Hz, 2H), 3.13–2.99 (m, 4H), 2.31–
2.07 (m, 4H), 2.07–1.79 (m, 2H), 1.46 ppm (br&&, 4H); 13C NMR:
d=170.9, 162.8, 159.5, 131.6, 126.7, 126.4, 53.6, 34.5, 26.0,
25.6 ppm; FTMS-NSI : m/z calcd for C28H28N8O14: 669.1659
[C26H26N10O12H] , found: 669.6663.
Synthesis of symmetrical deprotected derivatives NDIs 2
and 4
NDIs 1 and 3 served for the synthesis of the corresponding depro-
tected NDIs 2 and 4 by using the following general procedure: The
starting material was suspended in CH2Cl2 (5 mL) and trifluoroace-
tic acid (5 mL) was added to the suspension. The reaction mixture
was stirred at room temperature for 3 h. The solvents were re-
moved under reduced pressure, and the residue was subsequently
washed with diethyl ether (230 mL), filtered, and vacuum dried
to yield a brown powder in both cases.
NDI 2 :[49] The aforementioned general procedure was followed by
using NDI 1 (350 mg). Yield of NDI 2 : 332 mg, 91%; 1H NMR: d=
8.62 (s, 4H), 8.27 (br&&, 6H), 4.02 (t, J(H,H)=7.3 Hz, 4H), 3.96–3.84
(m, 2H), 1.91–1.60 (m, 8H), 1.57–1.29 ppm (m, 4H); 13C NMR: d=
171.4, 162.9, 158.8, 158.3, 130.8, 126.6, 126.4, 52.1, 50.1, 30.1, 28.9,
27.3, 24.0, 22.3 ppm; FTMS-NSI : m/z calcd for C30H30F6N4O12:
733.1566 [MH2OH] ; found: 733.1586.
Figure 9. a) The VT CD data of NDI 2, which fits to the isodesmic model as
a function of the degree of polymerisation. b)The Boltzmann fitting of the
NDI 2 melting curve (3104m in 10mm potassium phosphate buffer and
100mm potassium fluoride) of the maxima at 341 nm as a function of tem-
perature and associated thermodynamic parameters calculated at 298.15 K.
c) The CD spectrum of NDI 2 (3104m) at ambient temperature. d) The
structure of NDI 2.
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NDI 4 : The aforementioned general procedure was followed by
using NDI 3 (350 mg). Yield of NDI 4 : 102 mg, 33%; 1H NMR: d=
12.99 (s, 2H), 8.74 (s, 4H), 7.66 (s, 6H), 5.53 (dd, J(H,H)=9.0, 5.2 Hz,
2H), 2.87 (s, 1H), 2.80–2.64 (m, 4H), 2.34–2.17 (m, 2H), 2.13–1.92
(m, 2H), 1.63–1.21 ppm (m, 8H); 13C NMR: d=171.0, 162.8, 131.6,
126.7, 126.4, 53.6, 38.9, 28.4, 27.2, 23.2 ppm; FTMS-NSI: m/z calcd
for C30H30F6N4O12: 751.1667 [MH] ; found: 751.1692.
Variable-temperature studies
CD and UV/Vis experiments were performed on an Applied Photo-
physics Chirascan Circular Dichroism Spectrophotometer equipped
with a Peltier temperature controller under the following parame-
ters: wavelength scanning range 184–450 nm; scanning incre-
ments 1 nm; monochromator bandwidth 2.5 nm; sampling time-
per-point 2 s. The temperature range used for variable-temperature
studies was either 5–95 8C with 3 8C increments (c-kit2) or 5–90 8C
with 5 8C increments (other DNA sequences) ; temperature equili-
bration time 45 s. A 1 mm path-length quartz cuvette was used for
all experiments. The background spectrum of the buffer was re-
corded at 23 8C and was subtracted from all measurements. Each
measurement required 200 mL of the DNA sequence solutions and
10 equivalents of the ligand. The raw data were processed and an-
alysed by using two different programmes: Qtiplot and CD Apps.
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Amino-Acid-Derived
Naphthalenediimides as Versatile G-
Quadruplex Binders
Selective oncogene stablilisation :
Water-soluble, amino acid functionalised
naphthalenediimides are potential li-
gands of native G-quadruplexes, and
they are tested on a panel of oncogene
promoters and against double-strand
DNA. One of the ligands, NDI 3, exhibits
a highly discriminating nature by stabil-
ising only the oncogene promoter c-
kit2, which is overexpressed up to 80%
in ovarian, gastrointestinal, and breast
malignancies (see figure).
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